
Disease & Drugs
Research
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Research
ResearchNovo Nordisk Presents New Data on Residual Cardiovascular InflammationNovo Nordisk presented new data from the POSEIDON real-world evidence study at the European Atherosclerosis Society Congress, showing that cardiovascular inflammation remains widespread among patients with ASCVD, CKD…Fact-Checked
ResearchTeva Highlights the Unseen Psychological Toll of Tardive DyskinesiaNew real-world data from Teva’s IMPACT-TD Registry showed that young adults with tardive dyskinesia and underlying mood disorders had the lowest formal diagnosis rates despite experiencing high psychological…Fact-Checked
ResearchWhat Is Hantavirus? Understanding Its Spread, Structure, Symptoms, and RisksHantaviruses are rodent-borne viruses capable of causing severe kidney and respiratory disease in humans.Fact-Checked
ResearchNIH-Funded Study Finds Testosterone May Suppress Glioblastoma Growth in MenMagnific NIH-funded researchers reported in Nature that androgen loss accelerated glioblastoma growth in male mouse models through stress-hormone activation and…Fact-Checked
ResearchNIH-Funded Nature Study Finds Orforglipron Suppresses Pleasure-Driven Eating Through Brain Reward CircuitAn NIH-funded study published in Nature found that oral GLP-1 drugs such as Orforglipron may suppress pleasure-driven eating by targeting deep brain reward pathways linked to craving and…Fact-Checked
ResearchFibroBiologics Advancing Development of a Fibroblast Treatment for HantavirusFibroBiologics has expanded its fibroblast-based platform into Hantavirus pulmonary syndrome (HPS), a severe viral respiratory disease associated with high mortality and no approved disease-modifying treatments.Fact-Checked
ResearchJohnson & Johnson Pushes for Full Depression Recovery Through Generation FineJohnson & Johnson has expanded its “Generation Fine” campaign to encourage people living with major depressive disorder (MDD) to aim for remission rather than settling for feeling “fine.”…Fact-Checked
ResearchNeurocrine Builds a New Roadmap for Physiologic Steroid Dosing in CAHNeurocrine Biosciences has published the first structured clinical recommendations for glucocorticoid dose reduction in pediatric and adult patients with classic congenital adrenal hyperplasia treated with CRENESSITY (crinecerfont).Fact-Checked
ResearchNeurocrine Exposes the Silent Workplace Impact of Tardive DyskinesiaA new Neurocrine Biosciences survey found that many individuals living with tardive dyskinesia face major workplace and daily life challenges, with some reporting job loss, reduced responsibilities, and…Fact-Checked
ResearchZai Lab Highlights Long-Lasting Reduction in Pruritus and Inflammation with ZL-1503Preclinical findings presented at IMMUNOLOGY2026 show that ZL-1503, a dual IL-13/IL-31Rα inhibitor, achieved durable reductions in pruritus and inflammation across atopic disease models, with effects lasting up to…Fact-Checked
ResearchWhat Is the Optimal Time to Take Statins: Morning or Evening?Statins inhibit HMG-CoA reductase to slash LDL cholesterol, but timing matters—especially for short-acting types.Fact-Checked
ResearchSemaglutide Slows the Spiral of Worsening Mental IllnessA large Swedish cohort study in The Lancet Psychiatry reports that semaglutide was associated with significantly lower risk of worsening depression, anxiety, and self-harm in patients receiving antidiabetic…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.